| Product Code: ETC8275182 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Industry Life Cycle |
3.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Porter's Five Forces |
3.5 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Drug type, 2021 & 2031F |
3.6 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Mexico |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising demand for innovative cancer treatments |
4.3 Market Restraints |
4.3.1 High costs associated with CAR-T cell therapy |
4.3.2 Limited availability and accessibility of specialized healthcare facilities |
4.3.3 Regulatory challenges and approval processes for advanced therapies |
5 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Trends |
6 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Types |
6.1 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Drug type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Drug type, 2021- 2031F |
6.1.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Axicabtagene Ciloleucel, 2021- 2031F |
6.1.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Tisagenlecleucel, 2021- 2031F |
6.1.5 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Brexucabtagene Autoleucel, 2021- 2031F |
6.1.6 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Acute Lymphocytic Leukemia, 2021- 2031F |
6.2.4 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Cancer Treatment Centers, 2021- 2031F |
7 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Import-Export Trade Statistics |
7.1 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Export to Major Countries |
7.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Imports from Major Countries |
8 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Key Performance Indicators |
8.1 Average waiting time for CAR-T cell therapy treatment |
8.2 Number of clinical trials for CAR-T cell therapy in Mexico |
8.3 Patient satisfaction rate with CAR-T cell therapy outcomes |
9 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Opportunity Assessment |
9.1 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Drug type, 2021 & 2031F |
9.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Competitive Landscape |
10.1 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here